Vontobel Holding Ltd. Replimune Group, Inc. Put Options Transaction History
Vontobel Holding Ltd.
- $28.9 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding REPL
# of Institutions
191Shares Held
78.9MCall Options Held
1.72MPut Options Held
2.83M-
Baker Bros. Advisors LP New York, NY11MShares$58 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$56.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$24.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$24.5 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$20.5 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $259M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...